
Between 27 March to 1 April 2021, 9,025 medtech jobs were posted worldwide by 317 companies, according to the Globaldata jobs analytics tool.
This is a substantial decrease on the number of jobs reported in the last period, when 12,839 medtech jobs were posted worldwide by 332 companies, representing a listing decrease of almost 30%.
Cepheid UK posted the most jobs, with 645 listings, while Sonova Holding posted 472 jobs and Biotronik advertised for 446 positions.
UK opens applications for medtech business funding
The UK government has now opened the Medicines and Diagnostics Manufacturing Transformation Fund for applications, having announced the scheme last November.
The £20m scheme is intended to boost the UK’s ability to respond to future pandemics, as well as put the country ahead of global competitors.
UK Life Sciences Minister Nadhim Zahawi said: “I am thrilled to see this fund opening for applications and would encourage companies to make the most of the opportunity to expand their operations and create good jobs as we build back better from the pandemic.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe fund will support the manufacture of medicines, diagnostics and medtech in the UK, boosting the country’s life sciences sector and creating job opportunities across the country.
UK Business Secretary Kwasi Kwarteng said: “This will not only boost the UK’s already strong vaccine and medicine portfolio but support top quality, local jobs across the country and put the UK in a formidable position to continue responding to the most pressing global challenges of our time.”